Current status of gene therapy in Asia

Molecular Therapy

Volumn 16, Issue 2, 2008, Pages 237-243

  Kim, Sunyoung ^a   Peng, Zhaohui ^b   Kaneda, Yasufumi ^c  

^a Seoul National University   (South Korea)

^b SiBiono GeneTech ^*  (China)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOVIRUS VECTOR; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BETA 2 MICROGLOBULIN; BETA INTERFERON; BLOOD CLOTTING FACTOR 9; DNA VACCINE; ENDOSTATIN; FIBROBLAST GROWTH FACTOR 2; GLYCOPROTEIN GP 91; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HLA B7 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2; LIPOSOME; MULTIDRUG RESISTANCE PROTEIN 1; NAKED DNA; PARVOVIRUS VECTOR; PROTEIN P53; RETROVIRUS VECTOR; SCATTER FACTOR; THYMIDINE KINASE; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN 165; VIRUS VECTOR;

ASIA; BREAST CANCER; BUERGER DISEASE; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CHINA; CHRONIC GRANULOMATOUS DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DENDRITIC CELL; DRUG APPROVAL; ENZYME DEFICIENCY; ESOPHAGUS CANCER; GENE EXPRESSION REGULATION; GLIOMA; HEMOPHILIA; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISCHEMIA; JAPAN; KIDNEY CARCINOMA; KOREA; LEUKEMIA; LIMB ISCHEMIA; LUNG CANCER; LYMPHOCYTE ACTIVATION; MEDICAL RESEARCH; MELANOMA; NEOPLASM; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; OSTEOARTHRITIS; PARKINSON DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SENDAI VIRUS; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE;

EID: 38649091381     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300336     Document Type: Review

References (52)

1. Rosenberg, SA, Aebersold, P, Cornetta, K, Kasid, A, Morgan, RA, Moen, R et al. (1990). Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323: 570-578.
2. Blaese, RM, Culver, KW, Miller, AD, Carter, CS, Fleisher, T, Clerici, M et al. (1995). T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270: 475-480.
3. Gene Therapy Clinical Trials World Wide (2007). The Journal of Gene Medicine Clinical Trial site. WILEY .
4. Hacein-Bey-Abina, S, Von Kalle, C, Schmidt, M, McCormack, MP, Wulffraat, N, Leboulch, P et al. (2003), LMO2-associated clonal T cell proliferation in two patients after gene therapy-for SCID-X1. Science 302: 415-419.
5. Marshall, E (1999). Gene therapy death prompts review of adenovirus vector. Science 286: 2244-2245.
6. Lu, DR, Zhou, JM, Zheng, B, Qiu, XF, Xue, JL, Wang; JM et al. (1993). Stage I clinical trial of gene therapy for hemophilia B. Sci China B 36: 1342-1351.
7. Qiu, X, Lu, D, Zhou, J, Wang, J, Yang, J, Meng, P et al. (1996). Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients. Chin Med J (Engl) 109: 832-839.
8. Peng, Z (2005). Current status of gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther 16: 1016-1027.
9. Xia, ZJ, Chang, JH, Zhang, L, Jiang, WO, Guan, ZZ, Liu, JW et al. (2004). Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus. AnZheng 23: 1666-1670.
10. Zhu, C, Lu, YC, Wang, G, Bai, RL, Ding, XH, Cai, RJ et al. (2002). Gene therapy for brain glioma with RT-HSV thymidinekinase (TK) gene and ganciclovir system. Chin J Neurosurg Dis Res 1: 111-115.
11. Wang, KM, Qian, GX, Chen, SS, Zhang, J, Zhu, ZG, Wang, XL et al. (2003). Phase I clinical trial of interleukin-2 gene-modified allogenic gastric cancer cell line for the treatment of far-advanced gastric cancer. Chin J Dig 23: 523-526.
12. Wei, YQ, Wang, QR, Zhao, X, Yang, L, Tian, L, Lu, Y et al (2000). Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 6: 1160-1166.
13. Wei, YQ, Huang, MJ, Yang, L, Zhao, X, Tian, Lu, Y et al. (2001). Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA 98: 11545-11550.
14. Yin, H (2006). Regulations and procedures for new drug evaluation and approval in China. Hum Gene Ther 17: 970-974.
15. Onodera, M, Ariga, T, Kawamura, N, Kobayashi, I, Ohtsu, M, Yamada, M et al. (1998). Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency. Blood 91: 30-36.
16. Morishita, R, Aoki, M, Hashiya, N, Makino, H, Yamasaki, K, Azuma, J et al. (2004). Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44: 203-209.
17. Kawai, K, Tani, K, Yamashita, N, Tomikawa, S, Eriguchi, M, Fujime, M et al. (2002). Advanced renal cell carcinoma treated with granulocyte-macrophage colony-stimulating factor gene therapy: A clinical course of the first Japanese experience. Int J Urol 9 462-466.
18. Fujiwara, T, Tanaka, N, Kanazawa, S, Ohtani, S, Saijo, Y, Nukiwa, T et al. (2006). Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer. J Clin Oncol 24: 1689-1699.
19. Shimada, H, Matsubara, H, Shiratori, T, Shimizu, T, Miyazaki, S, Okazumi, S et al. (2006). Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. Cancer Sci 97: 554-561.
20. Fan, DS, Ogawa, M, Fujimoto, KI, Ikeguchi, K, Ogasawara, Y, Urabe, M et al. (1998). Behavioral recovery in 6-hydroxydopamine-lesioned rats by c- transduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum Gene Ther 9: 2527-2535.
21. Yoshida, J, Mizuno, M, Fujii, M, Kajita, Y, Nakahara, N, Hatano, M et al. (2004). Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes. Hum Gene Ther 15: 77-86.
22. Kataoka, K, Harada, A and Nagasaki, Y (2001). Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Deliv Rev 47: 113-131.
23. Kaneda, Y, Nakajima, T, Nishikawa, T, Yamamoto, S, Ikegami, Suzuki, N et al. (2002). Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 6: 219-226.
24. Kawashima, T, Kagawa, S, Kobayashi, N, Shirakiya, Y, Umeoka, T, Teraishi, F et al. (2004). Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res 10: 285-292.
25. Hanenberg, H, Xiao, XL, Dilloo, D, Hashino, K, Kato, I and Williams, DA (1996). Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 2: 876-882.
26. + cells to protect them against alkylating agents. Hum Gene Ther 8: 1901-1910.
27. Asada, K, Uemori, T, Ueno, T, Hashino, K, Koyama, N, Kawamura, A et al. (1998). Enhancement of retroviral gene transduction on a dish coated with a cocktail of two different polypeptides: One exhibiting binding activity toward target cells, and the other toward retroviral vectors. J Biochem (Tokyo) 123: 1041-1047.
28. Heo, DS, Yoon, SJ, Kim, WS, Lee, KH, Seol, JG, Lee, SG et al. (1998). Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/β2-microglobulin gene in patients with cancer. Hum Gene Ther 9: 2031-2038.
29. Kang, WK, Park, C, Yoon, HL, Kim, WS, Yoon, SS, Lee, MH et al. (2001). Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study. Hum Gene Ther 12: 671-684.
30. Kim, HJ, Jang, SY, Park, JI, Byun, I, Kim, DI, Do, YS et al. (2004). Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease. Exp Mol Med 36: 336-344.
31. Yang, SH, Lee, CG, Park, SH, Im, SJ, Kim, YM, Son, JM et al. (2006). Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: A proof-of-concept study. Gene ther 13: 1110-1117.
32. Kim, JH, Oh, JY, Park, BH, Lee, DE, Kim, JS, Park, HE et al. (2006). Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF. Mol Ther 14: 361-370.
33. Song, SU, Cha, YD, Han, JU, Oh, IS, Choi, KB, Yi, Y et al. (2005). Hyaline cartilage regeneration using mixed human chondrocyles and transforming growth factor-β1-producing chondrocytes. Tissue Eng 11: 1516-1526.
34. Lee, DK, Choi, KB, Oh, IS, Song, SU, Hwang, S, Lim, CL et al. (2005). Continuous transforming growth factor β1 secretion by cell-mediated gene therapy maintains chondrocyte redifferentiation. Tissue Eng 11: 310-318.
35. Yu, SS, Kim, JM and Kim, S (2000). High efficiency retroviral vectors that contain no viral coding sequences. Gene Ther 7: 797-804.
36. Yu, SS, Han, E, Hong, Y, Lee, JT, Kim, S and Kim, S (2003). Construction of a retroviral vector production system with the minimum possibility of a homologous recombination. Gene Ther 10: 706-711.
37. Kim, SH, Yu, SS, Park, JS, Robbins, PD, An, CS and Kim, S (1998). Construction of retroviral vectors with improved safety, gene expression, and versatility. J Virol 72: 994-1004.
38. Lee, Y, Park, EJ, Yu, SS, Kim, DK and Kim, S (2000). Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: Implication for gene therapy of ischemic diseases. Biochem Biophys Res Commun 272: 230-235.
39. Lee, SH, Son, MJ, Oh, SH, Rho, SB, Park, K, Kim, YJ et al. (2005). Thymosin β(10) inhibits angiogenesis and tumor growth by interfering with Ras function. Cancer Res 65: 137-148.
40. Lee, O, Lee, H, Nam, YR, Oh, JH, Cho, YH and Chang, JW (2005). Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models. Gene Ther 12: 1215-1222.
41. Kwon, BS, Jung, HS, Song, MS, Cho, KS, Kim, SC, Kimm, K et al. (2005). Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript. Mol Ther 12 824-834.
42. Ahn, J, Jun, ES, Lee, HS, Yoon, SY, Kim, D, Joo, CH et al. (2005). A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge. J Virol 79: 8620-8624.
43. Kim, MY and Jeong, S (2004). Inhibition of the functions of the nucleocapsid protein of human immunodeficiency virus-1 by an RNA aptamer. Biochem Biophys Res Commun 320: 1181-1186.
44. Lim, MJ, Min, SH, Lee, JJ, Kim, IC, Kim, JT, Lee, DC et al. (2006). Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors. Mol Ther 13: 899-909.
45. Min, SH, Lee, DC, Lim, MJ, Park, HS, Kim, DM, Cho, CW et al. (2006). A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA. J Gene Med 8: 1425-1434.
46. Song, JJ, Lee, B, Chang, JW, Kim, JH, Kwon, YK and Lee, H (2003). Óptimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity, with efficient gene transfer. Virus Res 93: 25-30.
47. Gardner, PS, Simpson, RE and White, GB (1957). Infection with virus in an outbreak of respiratory illness. Br Med J 1: 381-383.
48. Xue, JL, Lu, DR, Zhou, JM, Qiu, XF, Meng, PL, Wang, JM et al (1993). Phase I clinical trial of fibroblast on hemophilia B patients. Chinese Science 23: 53-60.
49. Qiu, XF, Lu, DR, Wang, HW, Xue, JE, Yang, JM, Meng, PL et al. (1996). The clinical trial of gene therapy on four hemophilia B patients. Journal of Fudan University (Natural Science) 35: 341-348.
50. Lin, S, Wang, ZC, Zhang, MZ, Li, JH, Zhe, JD, Jin, HI and Gu, JR (2004). Retrovirus/herpes simplex-thymidine kinase/ganciclovir comprex: Results of a phase clinical trial in patients with malignant gliomas. Chin J Neurosurg 20: 381-384.
51. Nasu, Y, Salka, T, Ebara, S, Kusaka, N, Kaku, H, Abarzua, F, et al. (2007). Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with-local recurrence of prostate cancer after hormonal therapy. Mol Ther 15:834-840.
52. Tani, K, Nakazaki, Y, Hase, H, Takahashi, K, Azuma, M, Ohita, J et al. (2000). Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells. Cancer Chemother Pharmacol 46 (suppl): S73-S76.